Indication
Chronic Lung Disease of Prematurity
2 clinical trials
2 products
Clinical trial
A Phase 2b, Multicenter, Randomized, Open-label, Two-Arm Study to Evaluate the Clinical Efficacy and Safety of OHB-607 in Preventing Chronic Lung Disease in Extremely Premature Infants Compared to Standard Neonatal CareStatus: Active (not recruiting), Estimated PCD: 2026-08-28
Product
OHB-607Clinical trial
Phase 1 Safety Trial of Recombinant Surfactant Protein D to Prevent Neonatal Chronic Lung DiseaseStatus: Not yet recruiting, Estimated PCD: 2024-07-01